Skip to main content
BIO CEO & Investor Conference Logo
Show Dates

  March 2-3, 2026・Miami, FL

BIO CEO & Investor Conference Logo
Show Dates

  March 2-3, 2026・Miami, FL

Presenting Companies

blue gradient

Loading
Filters
  • Stream
  • Date
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
9:30 AM
  1. Epion Therapeutics, Inc.
    Plymouth
    15 mins
    • Ophthalmology
    Michael Webb
    Michael Webb, CEO - Epion Therapeutics, Inc.
  2. Eupraxia Pharmaceuticals
    Royale
    15 mins
    • Gastrointestinal
    James Helliwell
    James Helliwell, CEO - Eupraxia Pharmaceuticals
9:45 AM
  1. Ashvattha Therapeutics, Inc.
    Plymouth
    15 mins
    • Ophthalmology
    Jeffrey Cleland
    Jeffrey Cleland, Chairman, CEO & President - Ashvattha Therapeutics, Inc.
  2. Dignify Therapeutics
    Royale
    15 mins
    • Gastrointestinal
    Tony DiTonno
    Tony DiTonno, CEO - Dignify Therapeutics
10:00 AM
  1. Carina Biotech Limited
    Plymouth
    15 mins
    • Gene/Cell Therapy
    Deborah Rathjen
    Deborah Rathjen, CEO & Managing Director - Carina Biotech Limited
  2. Sarcomatrix Therapeutics Corp.
    Royale
    15 mins
    • Multiple Therapeutics
    David Craig
    David Craig, President and CEO - Sarcomatrix Therapeutics Corp
10:15 AM
  1. GeoVax Labs, Inc.
    Plymouth
    15 mins
    • Immunology
    David Dodd
    David Dodd, Chairman & CEO - GeoVax Labs, Inc.
  2. Lexicon Pharmaceuticals
    Royale
    15 mins
    • Metabolic Diseases
    Mike Exton
    Mike Exton, CEO and Director - Lexicon Pharmaceuticals
10:30 AM
  1. EvastBio Inc
    Plymouth
    15 mins
    • Regenerative Medicine
    Matias Vial
    Matias Vial, CEO - Cells for Cells
  2. Pirouette
    Royale
    15 mins
    • Multiple Therapeutics
    Conor Cullinane
    Conor Cullinane, President, CEO - Pirouette Medical Inc.
10:45 AM
  1. Vaneltix Pharma, Inc.
    Plymouth
    15 mins
    • Reproductive/Sexual Health
    Dan Vickery
    Dan Vickery, President & CEO - Vaneltix Pharma, Inc.
  2. SirnaMed Therapeutics Inc.
    Royale
    15 mins
    • Oncology
    Jing-Zhou Hou
    Jing-Zhou Hou, Founder and CMO - SirnaMed Therapeutics Inc.
11:00 AM
  1. Daré Bioscience
    Plymouth
    15 mins
    • Reproductive/Sexual Health
    Sabrina Johnson
    Sabrina Johnson, President and CEO - Daré Bioscience
  2. MetasTx, LLC
    Royale
    15 mins
    • Oncology
    Harvey Homan
    Harvey Homan, CEO - MetasTx, LLC
11:15 AM
  1. Seek Labs
    Plymouth
    15 mins
    • Platform for Therapeutics
    Jared Bauer
    Jared Bauer, CEO & Co-Founder - Seek Labs
  2. Medicovestor, Inc
    Royale
    15 mins
    • Oncology
    Seah Lim
    Seah Lim, Chief Executive Officer - Medicovestor, Inc
11:30 AM
  1. Bound Therapeutics
    Plymouth
    15 mins
    • Platform for Therapeutics
    Yuanyuan Jin
    Yuanyuan Jin, Co-Founder & COO - Bound Therapeutics
  2. Cellinfinity Bio
    Royale
    15 mins
    • Oncology
    Premal Patel
    Premal Patel, CEO - Cellinfinity
1:15 PM
  1. Ananda Scientific Inc
    Plymouth
    15 mins
    • CNS/Neurological
    Sohail Zaidi
    Sohail Zaidi, CEO - Ananda Scientific Inc
  2. CNS Pharmaceuticals, Inc.
    Royale
    15 mins
    • Oncology
    John Climaco
    John Climaco, Chief Executive Officer - CNS Pharmaceuticals, Inc.
1:30 PM
  1. Sound Pharmaceuticals
    Plymouth
    15 mins
    • CNS/Neurological
    Jonathan Kil
    Jonathan Kil, CEO - Sound Pharmaceuticals, Inc.
  2. TrAMPoline Pharma Inc
    Royale
    15 mins
    • Oncology
    Richard Duke
    Richard Duke, President - TrAMPoline Pharma, Inc.
1:45 PM
  1. Tonix Pharmaceuticals
    Plymouth
    15 mins
    • CNS/Neurological
    Seth Lederman
    Seth Lederman, Chief Executive Officer - Tonix Pharmaceuticals Holding Corp.
  2. Radiopharm Theranostics
    Royale
    15 mins
    • Oncology
    Riccardo Canevari
    Riccardo Canevari, CEO - Radiopharm Theranostics
2:00 PM
  1. PathMaker Neurosystems Inc.
    Plymouth
    15 mins
    • CNS/Neurological
    Nader Yaghoubi
    Nader Yaghoubi, Co-Founder and CEO - PathMaker Neurosystems
  2. Lisata Therapeutics, Inc.
    Royale
    15 mins
    • Oncology
    David Mazzo
    David Mazzo, President and Chief Executive Officer - Lisata Therapeutics
2:15 PM
  1. KeifeRx
    Plymouth
    15 mins
    • CNS/Neurological
    Chris Hoyt
    Chris Hoyt, CEO - KeifeRx
  2. Greenwich LifeSciences
    Royale
    15 mins
    • Oncology
    Snehal PATEL
    Snehal PATEL, CEO - Greenwich Lifesciences, Inc.
2:30 PM
  1. Magdalena Biosciences, Inc.
    Plymouth
    15 mins
    • CNS/Neurological
    Karen Brunke
    Karen Brunke, Acting CEO - Magdalena Biosciences
  2. Rakuten Medical, Inc.
    Royale
    15 mins
    • Oncology
    Abhijit Bhatia
    Abhijit Bhatia, Chief Operating Officer - Rakuten Medical
2:45 PM
  1. NEWRON PHARMACEUTICALS SPA
    Plymouth
    15 mins
    • CNS/Neurological
    STEFAN WEBER
    STEFAN WEBER, CEO - Newron Pharmaceuticals SpA
  2. ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
    Royale
    15 mins
    • Oncology
    Wenzhi Tian
    Wenzhi Tian, Chairman, CEO and CSO - ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
3:00 PM
  1. ProMIS Neurosciences, Inc.
    Plymouth
    15 mins
    • CNS/Neurological
    Neil Warma
    Neil Warma, Chief Executive Officer - ProMIS Neurosciences
  2. Citius Pharmaceuticals
    Royale
    15 mins
    • Oncology
    Leonard Mazur
    Leonard Mazur, Chief Executive Officer - Citius Pharmaceuticals
3:15 PM
  1. NurrOn Pharmaceuticals, INC
    Plymouth
    15 mins
    • CNS/Neurological
    Deog Joong Kim
    Deog Joong Kim, CEO - NurrOn Pharmaceuticals, INC
  2. Asta Bio
    Royale
    15 mins
    • Oncology
    Ahmad-Reza Saadat
    Ahmad-Reza Saadat, Co-founder and CEO - Asta Bio
3:30 PM
  1. Bostal LLC
    Plymouth
    15 mins
    • CNS/Neurological
    Ron Liu
    Ron Liu, Chairman and CEO - Bostal LLC
  2. RNA Nanobiotics
    Royale
    15 mins
    • Oncology
    James Carroll
    James Carroll, President and CEO - RNA NanoBiotics
3:45 PM
  1. Can-Fite BioPharma, Ltd.
    Plymouth
    15 mins
    • Multiple Therapeutics
    Motti Farbstein
    Motti Farbstein, CEO - Can-Fite BioPharma, Ltd.
  2. Azitra Inc.
    Royale
    15 mins
    • Dermatology
    Travis Whitfill
    Travis Whitfill, Chief Operating Officer - Azitra Inc.
4:00 PM
  1. Cellphire Therapeutics, Inc
    Plymouth
    15 mins
    • Multiple Therapeutics
    Mike Gaffney
    Mike Gaffney, CEO - Cellphire Therapeutics, Inc
  2. Alphyn Biologics
    Royale
    30 mins
    • Dermatology
    Neal Koller
    Neal Koller, CEO - Alphyn Biologics
4:15 PM
  1. supernova bio
    Plymouth
    15 mins
    • Multiple Therapeutics
    Jay Junkeun Chang
    Jay Junkeun Chang, Founder & BOD Chairman - Supernova Bio
  2. Dimer Pharmaceuticals
    Royale
    15 mins
    • Other
    Rakhee Ganti
    Rakhee Ganti, Founder and CEO - Dimer Pharmaceuticals
4:30 PM
  1. Nanoscope Therapeutics
    Plymouth
    15 mins
    • Gene/Cell Therapy
    Sulagna Bhattacharya
    Sulagna Bhattacharya, CEO - Nanoscope Therapeutics
  2. Cadrenal Therapeutics, Inc.
    Royale
    15 mins
    • Cardiovascular
    Quang Pham
    Quang Pham, Chairman & Chief Executive Officer - Cadrenal Therapeutics, Inc.
9:15 AM
  1. Angiex Inc.
    Plymouth
    15 mins
    • Oncology
    Paul Jaminet
    Paul Jaminet, CEO - Angiex Inc.
9:30 AM
  1. Leukogene Therapeutics Inc.
    Plymouth
    15 mins
    • Oncology
    Sandeep Gupta
    Sandeep Gupta, CEO - Leukogene Therapeutics Inc
  2. Palatin Technologies, Inc.
    Royale
    15 mins
    • Inflammation
    Carl Spana
    Carl Spana, President & Chief Executive Officer - Palatin Technologies, Inc.
9:45 AM
  1. Multimeric Biotherapeutics, Inc.
    Plymouth
    15 mins
    • Oncology
    Richard Kornbluth
    Richard Kornbluth, President & Chief Scientific Officer - Multimeric Biotherapeutics, Inc.
  2. Sustained Therapeutics
    Royale
    15 mins
    • Pain Management
    William Annett
    William Annett, CEO - Sustained Therapeutics
10:00 AM
  1. Processa Pharmaceuticals, Inc.
    Plymouth
    15 mins
    • Oncology
    George Ng
    George Ng, Chief Executive Officer - Processa Pharmaceuticals, Inc.
  2. Artasome Therapeutics
    Royale
    15 mins
    • Orphan/Rare Diseases
    Bob Repella
    Bob Repella, CEO, Co-Founder - Artasome Therapeutics
10:15 AM
  1. VSPharmTech
    Plymouth
    15 mins
    • Oncology
    HO YUN NAM
    HO YUN NAM, Director - VSPharmTech
  2. Protalix BioTherapeutics Inc.
    Royale
    15 mins
    • Orphan/Rare Diseases
    Dror Bashan
    Dror Bashan, President, CEO - Protalix Biotherapeutics
10:30 AM
  1. Klotho Neurosciences, Inc.
    Plymouth
    15 mins
    • CNS/Neurological
    Joseph Sinkule
    Joseph Sinkule, Founder, Chief Executive Officer, Director and Chairman of the Board - Klotho Neurosciences, Inc
  2. BOOST Pharma
    Royale
    15 mins
    • Orphan/Rare Diseases
    Everhardus Kueppers
    Everhardus Kueppers, CEO - BOOST Pharma ApS
10:45 AM
  1. Xylyx Bio
    Plymouth
    15 mins
    • Regenerative Medicine
    John O'Neill
    John O'Neill, CSO - Xylyx Bio, Inc.
  2. EveryONE Medicines
    Royale
    15 mins
    • Orphan/Rare Diseases
    Kent Rogers
    Kent Rogers, CEO - EveryONE Medicines
11:00 AM
  1. Inhalon Biopharma, Inc.
    Plymouth
    15 mins
    • Respiratory
    John Whelan
    John Whelan, President and CEO - Inhalon Biopharma, Inc.
  2. Canopy Immuno-Therapeutics
    Royale
    15 mins
    • Immunology
    Kfir Oved
    Kfir Oved, Founder, CEO - Canopy Immuno Therapeutics
11:15 AM
  1. FibroBiologics
    Plymouth
    15 mins
    • Regenerative Medicine
    Pete OHeeron
    Pete OHeeron, Founder/CEO - FibroBiologics
  2. Ziphius LLC
    Royale
    15 mins
    • Infectious Diseases
    Jenny Maharjan
    Jenny Maharjan, Business Manager - Ziphius LLC
11:30 AM
  1. Akebia Therapeutics
    Plymouth
    15 mins
    • Other
    John Butler
    John Butler, Chief Executive Officer - Akebia Therapeutics
  2. Soligenix, Inc.
    Royale
    15 mins
    • Dermatology
    Christopher Schaber
    Christopher Schaber, President & CEO - Soligenix, Inc.
1:15 PM
  1. Gain Therapeutics
    Plymouth
    15 mins
    • CNS/Neurological
    Gene Mack
    Gene Mack, Chief Executive Officer - Gain Therapeutics
  2. Medera Biopharm
    Royale
    15 mins
    • Gene/Cell Therapy
    Ronald Li
    Ronald Li, CEO - Medera
1:30 PM
  1. EndeavourRx LLC
    Plymouth
    15 mins
    • CNS/Neurological
    Jeff Margolis
    Jeff Margolis, Senior Vice President, Chief Financial Officer, Treasurer, Secretary - Endeavourrx LLC
  2. Enveda
    Royale
    15 mins
    • Inflammation
    Bigyan Bista
    Bigyan Bista, SVP, Business Strategy & Development - Enveda
1:45 PM
  1. Johnson & Johnson
    Plymouth
    15 mins
    • Multiple Therapeutics
    Keisha Thomas
    Keisha Thomas, Senior Director, Early Innovation Partnering - Johnson & Johnson
  2. Pilatus Biosciences Inc.
    Royale
    15 mins
    • Oncology
    Raven Lin
    Raven Lin, CEO - Pilatus Biosciences
2:00 PM
  1. CuriOralRx
    Plymouth
    15 mins
    • Metabolic Diseases
    Indu Javeri
    Indu Javeri, President & CEO - CuriRx, Inc
2:15 PM
  1. Regor Therapeutics
    Plymouth
    15 mins
    • Metabolic Diseases
    Wenge Zhong
    Wenge Zhong, Co-Founder and CTO - Regor Therapeutics
2:30 PM
  1. Lipella Pharmaceuticals Inc.
    Plymouth
    15 mins
    • Orphan/Rare Diseases
    Jonathan Kaufman
    Jonathan Kaufman, Chief Executive Officer, Chairman and President - Lipella Pharmaceuticals Inc.
Testimonials
  • It's the kind of meeting where biotech newsmakers can have productive dialogs with investors and other key players.
    Luke Timmerman
    The Timmerman Report
  • It's the caliber of attendees - biopharma companies on the verge of their next big step and investors looking for smart opportunities - that make BIO CEO & Investor Conference vital to the industry.
    Anna Kazanchyan, MD
    Founder & CEO, Saghmos Therapeutics
  • The BIO CEO & Investor Conference offers a collaborative forum where executives, investors and industry stakeholders can come together to learn and exchange ideas about innovation in the biopharma ecosystem.
    Philip Ross, MD
    Global Chairman, J.P. Morgan Healthcare Investment Banking
  • The BIO CEO & Investor Conference provides timely and relevant content on the issues driving the business of biotech, along with an invaluable platform for networking and partnering.
    Chris Garabedian
    Chairman and CEO, Xontogeny and Portfolio Manager, PXV Fund

Double Helix

Loading

 

Supporting Bank Sponsor

Loading

 

Premier Sponsors

Loading

Conference Sponsors

Loading

 

Search